“…Besides Ac 4 GlcNAz and Ac 4 GalNAz, many other unnatural monosaccharide analogues have been synthesized (Figure ), including 1,3,4,6-tetra- O -acetyl- N -4-pentynylglucosamine (Ac 4 GlcNAlk), 1,3,4-tri- O -acetyl-2-deoxy-2- N -acetyl-6-deoxy-azidoglucopyranose (Ac 3 6AzGlcNAc), 1,3,6-tri- O -acetyl-2-azidoacetamido-2,4-dideoxy- d -glucopyranose (Ac 3 4dGlcNAz), 1,3,4-tri- O -acetyl-2-deoxy-2- N -acetyl-6-deoxy-alkynylglucopyranose (Ac 3 6AlkGlcNAc), 1,3,4,6-tetra- O -acetyl-2-azido-2-deoxyglucose (Ac 4 2AzGlc), , 1,3,4-tri- O -acetyl-2-azido-2-deoxyglucose (Ac 3 2AzGlc), 1,3,4,6-tetra- O -acetyl-6-azido-6-deoxy-glucose (Ac 4 6AzGlc), 1,3,4-tri- O -acetyl-2-acetamido-6-azido-2,6-dideoxy- d -galactopyranoside (Ac 3 6AzGalNAc), a glucosamine nitrobenzoxadiazole (GlcN-NBD) precursor (i.e., Ac 3 GlcN-β-Ala-NBD-α-1-P(Ac-SATE) 2 ), a diazirine-modified GlcNAc analogue Ac 3 GlcNDAz-1-P(Ac-SATE) 2 , and a methylcyclopropene GlcNAc analogue (Ac 4 GlcNCyoc). , After feeding cells with these metabolic probes, the unnatural analogues will partially replace the natural UDP-GlcNAc for O-GlcNAcylation. The resulting chemical handles on proteins can be derivatized via bioorthogonal reactions (e.g., with alkynyl- or azido-conjugated biotin) with subsequent imaging (using fluorescent or radionuclide-labeled avidins) for the detection of O-GlcNAcylation on proteins.…”